While single-cell CRISPR screens based on the WTA approach were limited to a few hundred perturbations, the targeted sequencing workflow presented here will allow genome-scale CRISPR screens.

Those who believe in clustered regularly interspaced short palindromic repeats (CRISPR) technology are cheering the recent approval for sickle cell disease by the United States Food and Drug ...

s PARP1 CRISPR plasmids are optimized for research use that can lead to disease treatment ... Overall, such solutions help scientists take the guesswork out of sensitive and multi-step gene editing ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

Preliminary research suggests that using CRISPR to treat cancer is safe in humans and could become a feasible therapeutic method in the future, although its efficacy is still unknown. Results from an ...

A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a point-of-care testing (POCT) system based on microfluidic CRISPR-Dx technology, ...

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and ...

To streamline and accelerate tool development, TMO has also integrated Gibson Assembly into its CRISPR workflows, making it easier to clone large DNA fragments efficiently. On December 20 ...

In addition, first-generation CRISPR systems (Cas9 and Cas12a) are too large for efficient in vivo delivery via a single adeno-associated viral (AAV) vector. Now, new preclinical research ...

Illumina, Inc. (NASDAQ: ILMN) has unveiled a series of roadmap innovations, establishing the industry's largest portfolio of ...